Literature DB >> 23574139

Understanding the core result of the National Lung Screening Trial.

David F Yankelevitz, James P Smith.   

Abstract

Mesh：

Year:  2013        PMID： 23574139     DOI： 10.1056/NEJMc1213744

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Lung cancer: Low-dose CT screening - determining the right interval.

Authors:  David Yankelevitz; Claudia Henschke
Journal:  Nat Rev Clin Oncol       Date:  2016-07-12       Impact factor: 66.675

Review 2.  Advancing and sharing the knowledge base of CT screening for lung cancer.

Authors:  David F Yankelevitz; Claudia I Henschke
Journal:  Ann Transl Med       Date:  2016-04

Review 3.  The importance of the regimen of screening in maximizing the benefit and minimizing the harms.

Authors:  Claudia I Henschke; Kunwei Li; Rowena Yip; Mary Salvatore; David F Yankelevitz
Journal:  Ann Transl Med       Date:  2016-04

4.  A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions.

Authors:  Andrea C Villanti; Yiding Jiang; David B Abrams; Bruce S Pyenson
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.